Get the Daily Brief
Latest Biotech News
Pioneering Stem Cell Method Advances Meiosis to Combat Infertility
Researchers at Harvard’s Wyss Institute have developed a novel stem cell differentiation protocol that induces meiosis directly from induced pluripotent stem cells (iPSCs), bypassing precursor...
Alzheimer’s Research Highlights Semaglutide and Microglial Lipid Dysfunction
New studies reveal promising Alzheimer’s treatments focusing on metabolic and immune mechanisms. Semaglutide, a GLP-1 receptor agonist known for diabetes control, is being evaluated in trials...
Innovative Cell and Viral Therapies Target Deadliest Cancers
Groundbreaking approaches in oncology are emerging, including engineered bacteria delivering oncolytic viruses directly into tumors, bypassing immune defenses for targeted destruction, and...
Emerging Neuropsychiatric Insights: PTSD, Parkinson’s, and Reproductive Disorders
Recent neuroscientific advances pinpoint cellular and molecular pathways underlying complex disorders. Single-nuclei RNA sequencing reveals PTSD leaves distinct gene expression "scars" in specific...
Chinese Biotech Hub Gains Momentum with Cost-Effective Manufacturing
Wuxi, near Shanghai, emerges as a premier biotech manufacturing and R&D hub challenging US dominance by prioritizing speed and cost efficiency over pioneering breakthroughs. The city hosts firms...
Advances in Electrochemical Sensors and Battery Anode Materials
Materials science breakthroughs promise enhancements in energy storage and environmental monitoring. Researchers developed a MoS2/nitrogen-doped carbon composite exhibiting high efficiency as a...
Neuralink Files as 'Disadvantaged Business' Amid $9B Valuation
Elon Musk’s Neuralink, developing brain-computer interfaces (BCI), controversially filed as a 'small disadvantaged business' in a federal filing shortly before closing a $650 million funding round...
Novel AI Models and Digital Pathology Illuminate Biomedical Frontiers
The integration of artificial intelligence in biology surges forward. A novel machine learning model precisely identifies 21,335 cytidine deaminase enzymes, enhancing protein function annotation...
Neuralink Files as Disadvantaged Business Amid $9 Billion Valuation
Neuralink, Elon Musk’s brain-computer interface startup developing technology to help paralyzed patients, recently classified itself as a 'small disadvantaged business' (SDB) in a federal filing....
FDA Approves Insmed’s Brensocatib for Non-CF Bronchiectasis
The FDA approved Insmed's Brensocatib, the first drug sanctioned to treat non-cystic fibrosis bronchiectasis (NCFB). This milestone brings a new targeted therapy to roughly 500,000 affected...
Stem Cell Technique Advances Human Meiosis Modeling for Infertility
Researchers at Harvard’s Wyss Institute developed a novel stem cell differentiation method that directly induces meiosis in human induced pluripotent stem cells, circumventing previous barriers...
Amyloid Beta Disrupts Microglia via Lipid Droplets in Alzheimer's
New research from Purdue University reveals amyloid β plaques trigger lipid droplet accumulation in microglia, impairing their ability to clear plaques and promoting sustained inflammation in...
Hatteras Venture Closes $200M Fund Amid VC Slowdown
Despite a challenging venture capital environment, Hatteras Venture Partners closed two new investment funds totaling $200 million, focused on seed- and early-stage biotech companies. The firm's...
Trojan Horse Bacteria Deliver Oncolytic Viruses in Cancer Therapy
Scientists engineered bacteria as Trojan horses to transport cancer-killing viruses directly into tumor cores, bypassing immune clearance. This targeted delivery system enables the virus to...
China’s Wuxi Emerges as Cost-Effective Pharma Biotech Hub
Wuxi, near Shanghai, is rapidly establishing itself as a premier biotech cluster, attracting global pharmaceutical companies seeking faster, cheaper drug development and manufacturing. Unlike U.S....
Meta-Analysis Links Environmental Sensitivity to Mental Health Risks
A comprehensive meta-analysis of 33 international studies establishes a robust association between high environmental sensitivity and increased incidence of common mental disorders including...
Dexamethasone Lower Dose Effective in Preventing Chemotherapy Reactions
A recent randomized controlled trial published in BMC Cancer demonstrated that a 10 mg dose of dexamethasone is non-inferior to higher doses in preventing hypersensitivity reactions (HSRs) from...
Nab-Paclitaxel Plus Cisplatin Outperforms Gemcitabine in Biliary Cancer
A multicenter phase II study in BMC Cancer reports that nab-paclitaxel combined with cisplatin shows superior efficacy versus gemcitabine therapy in advanced biliary tract cancer. Results indicate...
China's Biotech Hub Challenges US Dominance in Cost and Speed
China's biotechnology sector is rapidly expanding, leveraging a strategy that focuses on speeding up drug manufacturing and reducing costs. Wuxi, near Shanghai, has become a major hub where...
Trojan Horse Bacteria Deliver Viruses Against Tumors
Scientists have developed a novel cancer treatment employing engineered bacteria to transport oncolytic viruses directly into tumors, effectively evading immune detection. This 'Trojan horse'...